dPCR Assay Design and Optimization: Experiment Planning Guide

dPCR Platform Selection and Comparison

You've decided that dPCR is a good idea for your lab. But where do you start? The needs of a clinical diagnostic lab are very different from those of a low-budget research institution wanting to level up their qPCR experiments. Below is a quick overview of the existing dPCR systems with recommendations on who benefits the most from each of them.

Modular systems for flexibility

Modular dPCR platforms separate partition generation, thermal cycling, and detection, offering maximum experimental control. These suit research labs optimizing novel assays, processing variable sample volumes, or those who value protocol flexibility in general.

1. The Bio-Rad QX200 and QX600 systems (droplet-based, 20,000 partitions) require manual transfer of droplets to PCR plates and a separate thermocycler, providing two- or six-color detection for method development.
2. The Thermo Fisher QuantStudio Absolute Q uses microfluidic chip arrays with integrated dead-end partitions (~20,000) but retains modular components for workflow customization.

Fully automated systems

Integrated "sample-to-result" systems minimize user intervention and technical variability, great for routine analysis and throughput.

1. The Bio-Rad QX Continuum provides four-color detection with fully automated 96-well processing in ~six hours, ideal for qPCR users transitioning to absolute quantification.
2. The Bio-Rad QX700 series offers seven-color multiplexing with three throughput tiers, from 48 to 384 samples, and continuous loading capability.
3. The Qiagen QIAcuity utilizes nanoplate technology (26,000 partitions/well) with integrated thermal cycling and imaging, processing 24- or 96-well plates with <5 minutes hands-on time per run.

GMP-compliant systems

Good Manufacturing Practice (GMP) environments require 21 CFR Part 11 compliant software, audit trails, and RFID-tracked consumables.

1. The Bio-Rad QX ONE provides four-color detection with five-plate capacity (480 samples/day), featuring locked workflows.
2. The Qiagen QIAcuityDx offers dual-mode software (utility and IVD modes) with automated nanoplate processing and continuous loading for four plates, supporting GMP assay validation with full traceability.

Additionally, multiple models support upgrades for compliance.

IVD systems for clinical diagnostics

Regulatory-cleared systems enable clinical decision-making.

1. The Bio-Rad QXDx AutoDG (modular) is FDA-cleared and CE-IVD marked for the QXDx BCR-ABL %IS Test in CML monitoring, providing diagnostic-grade absolute quantification.
2. The Roche Digital LightCycler is CE-marked and FDA 510(k) exempt as an IVD platform, designed for infectious disease and oncology companion diagnostics.
3. The Qiagen QIAcuity holds CE-IVD marking for specific assays (e.g., CMV quantification), with clinical assay portfolios expanding.

It is worth mentioning that FDA clearance typically applies to specific system-assay combinations rather than the instrument alone.

Figure 2. An overview of which brands provide systems for dPCR in the automated, modular, GMP-compliant, or IVD-cleared categories, as of March 2026.

Wondering which applications benefit from dPCR? Read our in-depth article on dPCR applications and when to choose dPCR over qPCR.

dPCR Assay Design and Experimental Setup

The most common cause of dPCR experiment failure is poor design. Here you can learn about dPCR assay design best practices, including primer and probe design guidelines, and how to optimize your dPCR experiment.

Amplicon design

Amplicon sizes of 75–200 bp are ideal. Amplicon size affects PCR efficiency, so here are some general tips to keep it simple:

1. Try to use amplicons of similar sizes if you want to compare quantities of different target DNAs.
2. For ctDNA or FFPE samples with degraded or low-input DNA, you can go down to 60 bp.^1,2 Any shorter, and you risk detecting primer dimers instead of amplification.
3. ddPCR is able to amplify up to 1000 bp amplicons, so larger fragments can be chosen if needed.³

Primer specifications

Poor primer design is a leading cause of PCR failure, especially when using genomic DNA, as primers can bind to off-targets.⁴ Here’s a list of what to take into account when designing primers for ddPCR:⁵

1. GC content of 50–60 % is ideal.
2. Aim for a Tm of 50–65 °C.
3. Avoid more than three GCs in a row, or more than four of any base in a row.
4. Avoid primer dimers and 3′ complementarity.

To check these, we recommend using an online tool, inputting the sequence to check dimer probability and Tm according to your specific salt and primer concentration conditions. Many are available, like those from IDT, ThermoFisher, Eurofins, and others.

Probes

To measure fluorescence, TaqMan hydrolysis probes can be used. These provide high specificity, great for rare mutation detection, utilizing a 5′ fluorophore and a 3′ quencher with exonuclease-dependent signal generation during PCR. Some guidelines for these probes are:⁵

1. Probe Tm should exceed primer Tm by 3–10 °C (ideally 5–10 °C) to ensure probe binding during primer extension.
2. Keep probe length under 30 nucleotides.
3. Never position guanine at the 5′ end, as this quenches fluorescence even after hydrolysis.

EvaGreen or other intercalating dyes offer cost-effective alternatives for CNV or gene expression applications, detecting any dsDNA (including primer-dimers), but these dyes do not have the sequence specificity required for rare target detection.

Restriction enzymes

For CNV analysis or high-concentration genomic DNA, restriction enzyme digestion cuts DNA to prevent multiple copies of a gene from ending up on the same partition because they are on the same DNA fragment. For CNV analysis, this also prevents co-migration of reference and target loci into the same partitions.⁶

Without this, the distribution of DNA is not random, which violates the assumptions of Poisson distribution, so analysis cannot be performed accurately. Enzymes such as EcoRI are often used for this before dPCR.

Control strategies

It is always crucial to have robust controls to understand the data from samples.

1. No-template controls detect contamination through positive partitions at sample-equivalent intensities.
2. Positive controls with known copy numbers establish the limit of detection at ≥95 % detection rate and validate assay sensitivity.⁷
3. For CNV, reference genes require copy number stability (1:1 ratio in healthy samples).
4. Multiplexing multiple reference genes reduces measurement uncertainty compared to single-gene normalization.⁶

Multiplexing

When multiplexing, keep these things in mind to make sure that each target detection does not affect the others:

1. Select fluorophores with minimal spectral overlap and well-separated emission peaks (>30 nm emission peak separation is recommended to prevent bleed-through into adjacent detection channels).
2. Assign lower-intensity dyes to high-abundance targets (reference genes) and brighter dyes (FAM, Cy5) to rare targets to balance target frequency with dye intensity.
3. Optimize individual primer pairs before combining and avoid excessive primer concentrations in high-plex reactions to prevent primer dimers.
4. Always run single-plex controls alongside multiplex reactions to verify co-amplification does not alter quantification accuracy.

dPCR Experiment Setup: Workflow Execution and Critical Parameters

Every dPCR experiment setup follows the same core steps: sample preparation, partitioning, amplification, and detection. However, execution differs fundamentally between modular and integrated architectures. Below you can find the general workflow for each.

Modular workflow

Modular systems separate partitioning, thermal cycling, and detection into discrete steps. Users manually generate partitions (whether droplets via cartridges or chips via loaders), and then physically transfer sealed reactions to thermocyclers before final imaging or flow cytometry reading.

Figure 3: Modular workflows require manual transfer of samples to and from thermocyclers, which must be purchased independently.

This architecture permits custom cycling protocols (ramp rates, annealing optimization) and accommodates variable reaction volumes, but introduces transfer risks where partitions may break or leak, reducing effective counts below the 10,000-partition threshold required for reliable statistics.

Technical expertise is needed to handle the experiments and plates properly. Common dPCR troubleshooting issues include the "edge effect", where heating and cooling of the plate edge wells affect the reaction. 

If you see lower fluorescence, high rain populations, or variable partition counts on edge wells, you should avoid placing samples in the plate’s edge well, instead filling those wells with water/buffer. If you need the space, try to use heated lids or verify whether this issue is occurring using temperature-sensitive dyes to map well-to-well variation.

Want to know what your dPCR results mean and how to interpret them? Read our dPCR Data Analysis and Interpretation on dPCR data analysis, threshold setting, and results interpretation.

Automated workflow

Fully automatic systems perform partitioning, PCR, and imaging within sealed workflows.

Samples loaded into plates progress through microfluidic partitioning (droplet or nanoplate), thermal cycling, and fluorescence detection without user intervention. This reduces hands-on time to <30 minutes per batch. 

All you have to do is create the initial samples and load the system.

Universal critical parameters

Regardless of platform architecture, three parameters determine the success of any dPCR experiment:

1. Optimal dPCR DNA input is around 10–10,000 target DNA copies to avoid saturation.⁸ dPCR can work well with significantly more or less input DNA, but an order of magnitude higher or lower will yield bad results. If nearly all the partitions are positive, Poisson distribution cannot be used. Use absolute fluorometric quantification (Qubit) to accurately determine DNA quantity before dPCR. 

1. Partition count validation usually requires >10,000 accepted partitions per reaction.⁹ The more partitions, the more robust the experiment will be to high/low input DNA. 

1. Replicate strategy differs from qPCR: dPCR’s massive partitioning substitutes for technical replicates in most cases (for low-number applications like oncology ctDNA detection, technical replicates are still valuable), but four to six biological replicates are good practice to obtain statistical robustness.¹⁰

For good practice, you can always check the dMIQE guidelines (Minimum Information for Publication of Digital PCR Experiment), last updated in 2020. However, the latest instruments allow better dynamic ranges through more partitions and more reliable, automated processes.¹¹ Always check your instrument’s instructions.

This article is part of a 3-part series on digital PCR. Continue reading: 

• dPCR basics, dPCR vs qPCR, and when to use dPCR
• dPCR data analysis and results interpretation
• Inside the Application Digital PCR (dPCR) Hub

Frequently Asked Questions (FAQs)

References

1. Fernholz EC, Routman DM, et al. Detection, quantitation, and genotyping of human papillomavirus circulating tumor DNA by droplet digital PCR. J Clin Microbiol. 2025;63(9):e00585-25. https://doi.org/10.1128/jcm.00585-25

2. Oscorbin IP, Smertina MA, et al. Multiplex droplet digital PCR assay for detection of MET and HER2 genes amplification in non-small cell lung cancer. Cancers (Basel). 2022;14(6):1458. https://doi.org/10.3390/cancers14061458

3. Krumbholz M, Goerlitz K, et al. Large amplicon droplet digital PCR for DNA-based monitoring of pediatric chronic myeloid leukaemia. J Cell Mol Med. 2019;23(8):4955–4961. https://doi.org/10.1111/jcmm.14321

4. Andreson R, Möls T, et al. Predicting failure rate of PCR in large genomes. Nucleic Acids Res. 2008;36(11):e66. https://doi.org/10.1093/nar/gkn290

5. Ma L, Chung WK. Quantitative analysis of copy number variants based on real-time LightCycler PCR. Curr Protoc Hum Genet. 2014;80:7.21.1–7.21.8. https://doi.org/10.1002/0471142905.hg0721s80

6. Yener D, Busby EJ, et al. Multiplexed digital PCR reference gene measurement for genomic and cell-free DNA analysis. Cells. 2025;14(19):1544. https://doi.org/10.3390/cells14191544

7. Han X, Liu Y, et al. Establishment and application of a droplet digital PCR assay for sensitive detection of porcine deltacoronavirus. BMC Vet Res. 2025;22:12. https://doi.org/10.1186/s12917-025-05163-3

8. Souto S, Olveira JG, et al. Designing and validation of a droplet digital PCR procedure for diagnosis and accurate quantification of nervous necrosis virus in the Mediterranean area. Pathogens. 2023;12(9):1155. https://doi.org/10.3390/pathogens12091155

9. Cao Y, Raith MR, et al. Droplet digital PCR for simultaneous quantification of general and human-associated fecal indicators for water quality assessment. Water Res. 2015;70:337–349. https://doi.org/10.1016/j.watres.2014.12.008

10. Gross M, Stoeck T, et al. Comparing the precision of two digital PCR applications for copy number comparisons in protists. Sci Rep. 2025;15:27095. https://doi.org/10.1038/s41598-025-13143-8

11. The dMIQE Group and Huggett JF. The Digital MIQE Guidelines Update: Minimum Information for Publication of Quantitative Digital PCR Experiments for 2020. Clin Chem. 2020;66(8):1012–1029. https://doi.org/10.1093/clinchem/hvaa125